Literature DB >> 21034776

A versatile vector for the production of pseudotyped viruses expressing gp120 antigens from different clades of primary HIV-1 isolates.

Zheng Wang1, Mingshun Zhang, Yan Wang, Yanmei Jiao, Lu Zhang, Lin Li, Zuhu Huang, Hao Wu, Jingyun Li, Shan Lu, Shixia Wang.   

Abstract

A novel HIV-1 Env expression vector (SF162-Z) was developed by introducing two new cloning sites on the backbone of an existing vector that produces a full length Env from HIV-1 SF162 isolate. These sites facilitate the swapping of the gp120 portion of the SF162 Env with matching gp120 antigens from HIV-1 isolates of different genetic clades. Final production of functional pseudotyped viruses will express chimeric Env antigens, including gp41 of the parental SF162 and gp120 from other primary isolates. This system is useful for testing the neutralizing sensitivity of partial env gene products frequently identified in viral quasi species in patients infected with HIV or when only partial gp120 gene products are available.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034776      PMCID: PMC3011055          DOI: 10.1016/j.jviromet.2010.10.022

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  27 in total

1.  Neutralizing antibody quantification by flow cytometry.

Authors:  John R Mascola
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

2.  Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions.

Authors:  S Lu; R Wyatt; J F Richmond; F Mustafa; S Wang; J Weng; D C Montefiori; J Sodroski; H L Robinson
Journal:  AIDS Res Hum Retroviruses       Date:  1998-01-20       Impact factor: 2.205

3.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.

Authors:  Shixia Wang; James Arthos; John M Lawrence; Donald Van Ryk; Innocent Mboudjeka; Siyuan Shen; Te-Hui W Chou; David C Montefiori; Shan Lu
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.

Authors:  D C Montefiori; K A Reimann; M S Wyand; K Manson; M G Lewis; R G Collman; J G Sodroski; D P Bolognesi; N L Letvin
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

7.  Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

Authors:  D C Montefiori; G Pantaleo; L M Fink; J T Zhou; J Y Zhou; M Bilska; G D Miralles; A S Fauci
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

8.  Immunogenicities of Env glycoproteins from circulating HIV-1 isolates in China focusing on the strategy of "DNA prime plus protein boost".

Authors:  Zheng Wang; Shi-xia Wang; Si-yang Liu; Zuo-yi Bao; Dao-min Zhuang; Lin Li; Chun-hua Zhang; Lu Zhang; Jing-yun Li; Shan Lu
Journal:  Chin Med J (Engl)       Date:  2009-10-05       Impact factor: 2.628

9.  Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  P L Earl; R W Doms; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.

Authors:  D C Montefiori; R G Collman; T R Fouts; J Y Zhou; M Bilska; J A Hoxie; J P Moore; D P Bolognesi
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more
  1 in total

1.  DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.

Authors:  Mingshun Zhang; Lu Zhang; Chunhua Zhang; Kunxue Hong; Yiming Shao; Zuhu Huang; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.